Patents by Inventor Steven A. Kushner

Steven A. Kushner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120283323
    Abstract: The disclosure provides methods of treating cognitive disorders by administering a HMG CoA reductase inhibitor. Cognitive deficits treatable with the inhibitor compound include those associated with Angelman Syndrome, Neurofibromatosis-1, certain forms of X-linked mental retardation, tuberous sclerosis, Down Syndrome, autism, and attention deficit/hyperactivity disorder.
    Type: Application
    Filed: June 14, 2012
    Publication date: November 8, 2012
    Inventors: Alcino Silva, Yijun Cui, Weidong Li, Steven A. Kushner
  • Patent number: 8222293
    Abstract: The disclosure provides methods of treating cognitive disorders by administering a HMG CoA reductase inhibitor. Cognitive deficits treatable with the inhibitor compound include those associated with Angelman Syndrome, Neurofibromatosis-1, certain forms of X-linked mental retardation, tuberous sclerosis, Down Syndrome, autism, and attention deficit/hyperactivity disorder.
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: July 17, 2012
    Assignee: Regents of the University of Carolina
    Inventors: Alcino Silva, Yijun Cui, Weldong Li, Steven A. Kushner